The Effects of Homocysteine Level in the Critically Ill Patient. A Review

1. Miller AL, Kelly GS. Homocysteine Metabolism: Nutritional Modulation and Impact on Health and Disease Homocysteine. Alt Med Rev. 1997;2(4):234-254.Search in Google Scholar

2. Eldeen ON, Abd Eldayem SM, Shatla RH, Omara N, Elgammal SS. Homocysteine, folic acid and vitamin B12 levels in serum of epileptic children. Egypt J Med Hum Genet. 2012;13(3):275-280.10.1016/j.ejmhg.2012.05.002Search in Google Scholar

3. Schaffer A, Verdoia M, Cassetti E, Marino P, Suryapranata H, De Luca G. Relationship between homocysteine and coronary artery disease. Results from a large prospective cohort study. Thromb Res. 2014.134:288-93.10.1016/j.thromres.2014.05.02524928335Search in Google Scholar

4. Christie L, Riedel G, Algaidi S, Whalley LJ, Platt B. Enhanced hippocampal long-term potentiation in rats after chronic exposure to homocysteine. Neurosci Lett. 2005;373:119-124.10.1016/j.neulet.2004.09.07215567565Search in Google Scholar

5. Kloppenborg RP, Nederkoorn PJ, van der Graaf Y, Geerlings MI. Homocysteine and cerebral small vessel disease in patients with symptomatic atherosclerotic disease. The SMART-MR study. Atherosclerosis. 2011;216(2):461-466.10.1016/j.atherosclerosis.2011.02.02721411090Search in Google Scholar

6. de Jager C. Critical levels of brain atrophy associated with homocysteine and cognitive decline. Neurobiol Aging. 2014;35:S35-S39.10.1016/j.neurobiolaging.2014.03.04024927906Search in Google Scholar

7. Jendricko T, Vidović A, Grubisić-Ilić M, Romić Z, Kovacić Z, Kozarić-Kovacić D. Homocysteine and serum lipids concentration in male war veterans with posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(1):134-140.10.1016/j.pnpbp.2008.11.00219038303Search in Google Scholar

8. Douaud G, Refsum H, Jager CA De, Jacoby R, Nichols TE. Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment. Gwenaëlle Douaud. 2013;110:9523-9528.10.1073/pnas.1301816110367745723690582Search in Google Scholar

9. Song IU, Kim JS, Park IS, et al. Clinical significance of homocysteine (hcy) on dementia in Parkinson’s disease (PD). Arch Gerontol Geriatr. 2013;57(3):288-291.10.1016/j.archger.2013.04.01523706974Search in Google Scholar

10. Allam A, Ammar H, Radwan A. Serum homocysteine level and eye involvement in Egyptian patients with Behçet’s disease. Egypt Rheumatol. 2014;36(1):29-34.10.1016/j.ejr.2013.09.002Search in Google Scholar

11. Wijngaarden JP Van, Doets EL, Szczeci N, et al. Vitamin B 12, Folate, Homocysteine, and Bone Health in Adults and Elderly People: A Systematic Review with Meta-Analyses. J Nutr Metab. 2013;2013.10.1155/2013/486186359081623509616Search in Google Scholar

12. Ramakrishnan S, Sulochana KN, Lakshmi S, Selvi R, Angayarkanni N. Biochemistry of homocysteine in health and diseases. Indian J Biochem Biophys. 2006;43:275-283.Search in Google Scholar

13. Ruseva S, Lozanov V, Markova P, Girchev R, Mitev V. In vivo investigation of homocysteine metabolism to polyamines by high-resolution accurate mass spectrometry and stable isotope labeling. Anal Biochem. 2014;457:38-47.10.1016/j.ab.2014.04.00724736325Search in Google Scholar

14. Lippi G, Mattiuzzi C, Meschi T, Cervellin G, Borghi L. Homocysteine and migraine. A narrative review. Clin Chim Acta. 2014;433:5-11.10.1016/j.cca.2014.02.02824613517Search in Google Scholar

15. Tehlivets O, Malanovic N, Visram M, Pavkov-Keller T, Keller W. S-adenosyl-L-homocysteine hydrolase and methylation disorders: Yeast as a model system. Biochim Biophys Acta - Mol Basis Dis. 2013;1832(1):204-215.10.1016/j.bbadis.2012.09.007378773423017368Search in Google Scholar

16. Maclean KN, Sikora J, Kožich V, et al. Cystathionine beta-synthase null homocystinuric mice fail to exhibit altered hemostasis or lowering of plasma homocysteine in response to betaine treatment. Mol Genet Metab. 2010;101:163-171.10.1016/j.ymgme.2010.06.007295435820638882Search in Google Scholar

17. Meng X, Ye W, Wang S, et al. A ratiometric two-photon fluorescent probe for cysteine and homocysteine in living cells. Sensors Actuators, B Chem. 2014;201:520-525.10.1016/j.snb.2014.05.042Search in Google Scholar

18. Wei X, Gong C, Gou M, et al. Biodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) copolymers as drug delivery system. Int J Pharm. 2009;381(1):1-18.10.1016/j.ijpharm.2009.07.03319664700Search in Google Scholar

19. Choe YM, Sohn BK, Choi HJ, et al. Association of homocysteine with hippocampal volume independent of cerebral amyloid and vascular burden. Neurobiol Aging. 2014;35(7):1519-1525.10.1016/j.neurobiolaging.2014.01.01324524964Search in Google Scholar

20. Lan T-H, Xu Z-W, Wang Z, Wu Y-L, Wu W-K, Tan H-M. Ginsenoside Rb1 prevents homocysteine-induced endothelial dysfunction via PI3K/Akt activation and PKC inhibition. Biochem Pharmacol. 2011;82(2):148-155.10.1016/j.bcp.2011.04.00121515242Search in Google Scholar

21. Jeong S-K, Kim D-H, Cho YI. Homocysteine and pulsatility index in lacunar infarction. Clin Neurol Neurosurg. 2011;113(6):459-463.10.1016/j.clineuro.2011.01.01621371817Search in Google Scholar

22. Agnati LF, Genedani S, Rasio G, et al. Studies on homocysteine plasma levels in Alzheimer’s patients. Relevance for neurodegeneration. J Neural Transm. 2005;112:163-169.10.1007/s00702-004-0154-715599614Search in Google Scholar

23. Genedania S, Rasiob G, Cortellic P, et al. Studies on Homocysteine and Dehydroepiandrosterone Sulphate Plasma Levels in Alzheimer’s Disease Patients and in Parkinson’s Disease Patients. Neurotox Res. 2004;6(4):327-332.10.1007/BF0303344315545016Search in Google Scholar

24. Jami M-S, Pal R, Hoedt E, Neubert T, Larsen JP, Møller SG. Proteome analysis reveals roles of L-DOPA in response to oxidative stress in neurons. BMC Neurosci. 2014;15:93.10.1186/1471-2202-15-93412569225082231Search in Google Scholar

25. Bouaziz N, Ayedi I, Sidhom O, et al. Plasma homocysteine in schizophrenia: Determinants and clinical correlations in Tunisian patients free from antipsychotics. Psychiatry Res. 2010;179:24-29.10.1016/j.psychres.2010.04.00820471108Search in Google Scholar

26. Nagaraja D, Noone ML, Bharatkumar VP, Christopher R. Homocysteine, folate and vitamin B(12) in puerperal cerebral venous thrombosis. J Neurol Sci. 2008;272(1-2):43-47.10.1016/j.jns.2008.03.02118617193Search in Google Scholar

27. Glover AT, Shaw SM, Williams SG, Fildes JE. Can inflammation be an independent predictor of depression? Brain Behav Immun. 2010;24(2):173;174-175.10.1016/j.bbi.2009.11.00819932747Search in Google Scholar

28. Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav Immun. 2007;21(7):901-912.10.1016/j.bbi.2007.03.01117475444Search in Google Scholar

29. Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 2006;580:2994-3005.10.1016/j.febslet.2006.04.08816697371Search in Google Scholar

30. Möller M, Du Preez JL, Viljoen FP, Berk M, Emsley R, Harvey BH. Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine. Brain Behav Immun. 2013;30:156-167.10.1016/j.bbi.2012.12.01123270677Search in Google Scholar

31. Enneman a W, Swart KM a, Zillikens MC, et al. The association between plasma homocysteine levels and bone quality and bone mineral density parameters in older persons. Bone. 2014;63:141-146.10.1016/j.bone.2014.03.00224631997Search in Google Scholar

32. Ataie A, Ataee R, Mansoury Z, Aghajanpour M, Sciences M. Homocysteine Intracerebroventricular Injection Induces Apoptosis in the Substantia Nigra Cells and Parkinson’s Disease Like Behavior in Rats. Int J Mol Cell Med. 2013;(3):2-7.Search in Google Scholar

33. Bertoia ML, Pai JK, Cooke JP, et al. Plasma homocysteine, dietary B vitamins, betaine, and choline and risk of peripheral artery disease. Atherosclerosis. 2014;235(1):94-101.10.1016/j.atherosclerosis.2014.04.010410231024819748Search in Google Scholar

34. Schnabel R, Lackner KJ, Rupprecht HJ, et al. Glutathione peroxidase-1 and homocysteine for cardiovascular risk prediction: results from the AtheroGene study. J Am Coll Cardiol. 2005;45(10):1631-1637.10.1016/j.jacc.2005.02.05315893179Search in Google Scholar

35. Maric T, Woodside B, Luheshi GN. The effects of dietary saturated fat on basal hypothalamic neuroinflammation in rats. Brain Behav Immun. 2014;36:35-45.10.1016/j.bbi.2013.09.01124075847Search in Google Scholar

36. Giustarini D, Fanti P, Sparatore A, Matteucci E, Rossi R. Anethole dithiolethione lowers the homocysteine and raises the glutathone levels in solid tissues and plasma of rats: A novel non-vitamin homocysteine-lowering agent. Biochem Pharmacol. 2014;89(2):246-254.10.1016/j.bcp.2014.03.005414242024637238Search in Google Scholar

37. Amorim De Farias Leal A, Camêlo Palmeira Á, et al. Homocysteine: cardiovascular risk factor in children and adolescents? Rev Assoc Med Bras. 2013;59(6):622-628.10.1016/j.ramb.2013.05.00424182942Search in Google Scholar

38. Santos MERC, Das CLE Silva F, Gomes KB, et al. Mutations in methylenetetrahydrofolate reductase and in cysthationine beta synthase: Is there a link to homocysteine levels in peripheral arterial disease? Mol Biol Rep. 2011;38:3361-3366.Search in Google Scholar

39. Zoccolella S, Tortorella C, Iaffaldano P, et al. Elevated plasma homocysteine levels in patients with multiple sclerosis are associated with male gender. J Neurol. 2012;259:2105-2110.10.1007/s00415-012-6464-z22421956Search in Google Scholar

40. Liu Y, Tian T, Zhang H, Gao L, Zhou X. The effect of homocysteine-lowering therapy with folic acid on flow-mediated vasodilation in patients with coronary artery disease: A meta-analysis of randomized controlled trials. Atherosclerosis. 2014;235(1):31-35.10.1016/j.atherosclerosis.2014.03.03224814647Search in Google Scholar

41. Stoiser B, Thalhammer F, El-Menyawi I, et al. Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome. Clin Diagn Lab Immunol. 2000;7(1):119-121.10.1128/CDLI.7.1.119-121.20009583510618290Search in Google Scholar

42. Konrad C, Müller G a., Langer C, et al. Plasma homocysteine, MTHFR C677T, CBS 844ins68bp, and MTHFD1 G1958A polymorphisms in spontaneous cervical artery dissections. J Neurol. 2004;251(10):1242-1248.10.1007/s00415-004-0523-z15503105Search in Google Scholar

43. Kuyumcu ME, Yesil Y, Oztürk ZA, et al. The association between homocysteine (hcy) and serum natural antioxidants in elderly bone mineral densitometry (BMD). Arch Gerontol Geriatr. 2012;55(3):739-743.10.1016/j.archger.2012.05.00422682423Search in Google Scholar

44. Poloni S, Leistner-Segal S, Bandeira IC, et al. Body composition in patients with classical homocystinuria: body mass relates to homocysteine and choline metabolism. Gene. 2014;546(2):443-447.10.1016/j.gene.2014.05.01524815046Search in Google Scholar

45. Rehackova P, Skalova S, Kutilek S. Serum homocysteine levels in children and adolescents with impaired bone health. Rev Bras Reumatol. 2013;53(6):464-469.10.1016/j.rbr.2013.06.00124477724Search in Google Scholar

46. Tyagi N, Vacek TP, Fleming JT, Vacek JC, Tyagi SC. Hyperhomocysteinemia decreases bone blood flow. Vasc Health Risk Manag. 2011;7:31-35.Search in Google Scholar

47. Ploder M, Kurz K, Spittler A, Neurauter G, Roth E, Fuchs D. Early increase of plasma homocysteine in sepsis patients with poor outcome. Mol Med. 2010;16:498-504.10.2119/molmed.2010.00008297239520386870Search in Google Scholar

48. Omar A, El-Shahat N, Ramadan MM. Cardiac functions in patients with sepsis and septic shock. Egypt Hear J. 2012;64(4):191-196.10.1016/j.ehj.2012.07.002Search in Google Scholar

49. Bramlett K, Onel E, Viscusi ER, Jones K. A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty. Knee. 2012;19(5):530-536.10.1016/j.knee.2011.12.00422285545Search in Google Scholar

50. Lee LM, Chang LC, Wrobleski S, Wakefield TW, Yang VC. Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): preliminary in vivo evaluation of efficacy and toxicity using a canine model. AAPS PharmSci. 2001;3(2):E19.10.1208/ps030319275101411741270Search in Google Scholar

51. Wang C, Chen Z, Zhang T, et al. Elevated plasma homocysteine level is associated with ischemic stroke in Chinese hypertensive patients. Eur J Intern Med. 2014;25(6):538-544.10.1016/j.ejim.2014.04.01124824758Search in Google Scholar

52. Zeckey C, Dannecker S, Hildebrand F, et al. Alcohol and multiple trauma: is there an influence on the outcome? Alcohol. 2011;45(3):245-251.10.1016/j.alcohol.2010.08.00420843639Search in Google Scholar

53. Shuwei D, Shuwen L, Xuefeng S, et al. Potential association of hyperhomocysteinemia with the. Chim Med J. 2014;127(10).Search in Google Scholar

54. Shepherd L, Wild J. Emotion regulation, physiological arousal and PTSD symptoms in trauma-exposed individuals. J Behav Ther Exp Psychiatry. 2014;45(3):360-367.10.1016/j.jbtep.2014.03.002405358924727342Search in Google Scholar

55. Ontario HQ. Vitamin B12 and cognitive function: an evidence-based analysis. Ont Health Technol Assess Ser. 2013;13(23):1-45.Search in Google Scholar

56. Pascoe MC, Crewther SG, Carey LM, Noonan K, Crewther DP, Linden T. Homocysteine as a potential biochemical marker for depression in elderly stroke survivors. Food Nutr Res. 2012;1:1-5.10.3402/fnr.v56i0.14973332634222509143Search in Google Scholar

57. Fazal N, Shelip A, Alzahrani AJ. Burn-injury affects gut-associated lymphoid tissues derived CD4+ T cells. Results Immunol. 2013;3:85-94.10.1016/j.rinim.2013.09.001390833324600563Search in Google Scholar

58. Moorthy D, Peter I, Scott TM, et al. Status of Vitamins B-12 and B-6 but Not of Folate, Homocysteine, and the Methylenetetrahydrofolate Reductase C677T Polymorphism Are Associated with Impaired Cognition and Depression in Adults. J Nutr. 2012;142(8):1554-1560.10.3945/jn.112.161828339734022739363Search in Google Scholar

59. Nachum-biala Y, Troen AM. B-vitamins for neuroprotection: Narrowing the evidence gap. Biofactors. 2012;38(2):145-150.10.1002/biof.100622419558Search in Google Scholar

60. Koz ST, Etem EO, Baydas G, et al. Effects of resveratrol on blood homocysteine level, on homocysteine induced oxidative stress, apoptosis and cognitive dysfunctions in rats. Brain Res. 2012;1484:29-38.10.1016/j.brainres.2012.09.02622995369Search in Google Scholar

61. Ohashi R, Yan S, Mu H, et al. Effects of homocysteine and ginsenoside Rb1 on endothelial proliferation and superoxide anion production. J Surg Res. 2006;133(2):89-94.10.1016/j.jss.2005.09.01616271366Search in Google Scholar